Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...

Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the December 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other most promising gene ...

and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq ... LNP technology to exploit mRNA-CRISPR Cas12a-LNP products directed ...

We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a ...

Deep-pocketed investors have adopted a bearish approach towards Capricor Therapeutics (NASDAQ:CAPR), and it's ... CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine. After a thorough review of ...

Current Moderna shareholders who have held Moderna shares since on or before January 18, 2023, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a ...

Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.

Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...

CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Present at the 12th Interna ...